Leavitt Partners News

Leavitt Partners News

Digital Health Leader Joins Leavitt Partners

Leavitt Partners, an HMA Company, is pleased to announce that Mark Marciante has joined the company’s digital health team of experts. He will be a director located in the company’s Washington, D.C., office. Marciante has extensive experience in digital health, successfully driving transformative initiatives for healthcare payers over the past decade. As director of engineering … Read more

New Task Force Endorses Legislation to Save Rare Disease Treatments 

The Save Rare Treatments Task Force, a new multi-sector public policy and advocacy collaboration convened by Leavitt Partners, an HMA Company, publicly launched this week and today released a letter of support for recently introduced, bipartisan, bicameral legislation. The Task Force is comprised of organizations representing persons living with rare diseases, biopharmaceutical innovators, and other … Read more

A Vision for Consumer Engagement in Health 

Rebecca Nielsen, Managing Director, Leavitt Partners, an HMA CompanySpencer Morrison, Associate Principal, Leavitt Partners, an HMA Company  PillPack boasts the tagline, “Pharmacy Simplified.” The mail-order pharmacy successfully streamlined the activities associated with managing medications. It illuminated for its customers what medications they needed to take next, and at what time, by packaging meds in a … Read more

Amy Comstock Rick Joins Leavitt Partners, an HMA Company

Amy Comstock Rick, former president and chief executive officer (CEO) of the Food and Drug Law Institute (FDLI), joined Leavitt Partners, an HMA Company as a principal on March 20. Rick has over 30 years of experience leading organizations, executing strategy, transforming organizational culture, building consensus, and advocating policies across constituencies. “Amy is widely respected … Read more

CARIN Alliance and HHS Release Digital Identity Federation Report about their Test Proof of Concept

Washington, D.C., March 22, 2023 — The CARIN Alliance, a multi-sector collaborative of healthcare and other stakeholders working to advance the consumer-directed exchange of health information released a report today that lays the foundation for how individuals can voluntarily digital identity proof themselves once and use that same digital credential with multiple data holders of … Read more

Leavitt Center for Alliances, an HMA Initiative, Drives Collaboration and Solutions

Today, Health Management Associates (HMA) launched the Leavitt Center for Alliances, an HMA Initiative, which aims to elevate the national discourse on healthcare and help healthcare organizations solve their most complex challenges through consensus-based alliances. The Leavitt Center for Alliances (Leavitt Center) is home to expert conveners who have decades of experience in the private … Read more

The CARIN Alliance Announces Code of Conduct Accreditation Program with EHNAC

Consumer health app developers are finding ways to help consumers and their physicians make better use of their health data. These apps can now get accredited for their compliance with best practices in managing personal health information, an important step towards building trust that consumers’ health data will be protected as it is moved more … Read more

New Partnership Launches to Advance Access to Care and Treatment, Improve Outcomes for Individuals with Sickle Cell Disease

Partnership Calls on Policymakers to Implement Proposals in 2020 Landmark Report Washington, D.C. — In recognition of World Sickle Cell Day on June 19th, today more than a dozen organizations representing a diverse cross-section of patient advocates, health professional organizations, health insurers and biopharmaceutical companies announced the launch of the Sickle Cell Disease Partnership. The … Read more

New Health Affairs Forefront Article: Imminent VFC Decisions are Critical for RSV Therapy Access

As respiratory syncytial virus (RSV), a seasonal pathogen in young children is challenging the national health care system as part of an unprecedented “tripledemic” with COVID-19 and flu this winter, authors with Leavitt Partners parent company Health Management Associates weigh in on potential coverage pathways for new monoclonal antibody (mAb) preventive therapies for RSV and … Read more